pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Icotyde · news · pharmadog
← back to Icotyde
News mentioning Icotyde
12
stories
13d
J&J and Protagonist’s Icotyde improves psoriatic arthritis but AbbVie’s Skyrizi likely to reign
biospace
13d
Argenx inks $1.15B Unnatural Products buyout to expand in oral peptides
fiercebiotech
20d
China's InventisBio delivers competitive TYK2 data in phase 3 psoriasis win
fiercebiotech
25d
5 new drug launches that defied industry expectations
biospace
27d
Another autoimmune CAR-T death; Treasury zeroes in on China deals
biopharma dive
Oct 23, 26
Gilead to pay $1.3B upfront for PepStar’s oral IL-23 challenger to J&J’s Icotyde
fiercebiotech
Oct 15, 26
Chutes & Ladders—Bausch + Lomb's returning CEO Saunders exits again
fiercebiotech
Oct 13, 26
J&J’s innovative medicines carried Q3 as medtech disappoints, but newer medicines absent
biospace
Sep 28, 26
6 immunology targets to sustain a mammoth I&I market
biospace
Sep 16, 26
5 biotechs braving the commercial waters with product launches
biospace
Jul 15, 26
J&J touts Icotyde prescriptions, but not sales, in first full quarter
endpoints
Jul 14, 26
Fresh off buyout, Akero execs reunite to advance long-acting psoriasis pill
biopharma dive